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ABSTRACT
Upper gastrointestinal bleeding is one of the emergency conditions in the field of gastroenterology and
variceal bleeding is the most common cause of it. Gastric varices accounts only 5%  to 10% of all causes of
upper gastrointestinal bleeding respectively, but it could be fatal and difficult to control despite provision of
adequate therapy. Early diagnosis and appropriate management may decrease the morbidity and mortality
of gastric variceal bleeding.
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INTRODUCTION
Upper gastrointestinal bleeding is one of emergency
conditions in the field gastroenterology. In the US, it had
caused 10,000-20,000 deaths per year with the
prevalence of 150 per 100,000 populations. In Cipto
Mangunkusumo General National Hospital we found
respectively 200-300 cases of upper gastrointestinal
bleeding with mortality rate of 26% in 1998.1 The most
common cause of these was variceal bleeding which
had high morbidity and mortality rate. More than 30% of
initial variceal bleeding would be fatal and the rest 70%
would have recurrence of bleeding.2 Most of variceal
bleeding caused by rupture of esophageal varices, while
gastric varices was responsible only 5% of all cases.3
However, gastric variceal bleeding may become fatal
and difficult to control even by endoscopic treatment.4
The management of variceal bleeding prevention
consists of 3 phases as follows:4
1. Primary prevention is to prevent the occurrence of
initial variceal bleeding
2. Secondary prevention is to prevent the recurrence
of bleeding
3. Tertiary prevention is to stop the active bleeding
DEFINITION AND CLASSIFICATION
Gastric varices is defined as dilatation of gastric
collateral vein in the submucosa.3,5 Collateral system in
the portal vein has important role in the pathogenesis of
gastric varices. Portal vein originates from splenic vein,
superior mesenteric vein and inferior mesenteric vein
and left gastric vein. Superior mesenteric vein receive
blood from colon and intestine, while the inferior
mesenteric vein and hyllus joint short gastric vein in
caudal part of pancreas. Left gastric vein will receive
the blood flow from esophagus and stomach.6,7
Gastric varices is classified as gastroesophageal
varices or isolated gastric varices. Type I
gastroesophageal varices is the continuity of esophageal
varices and only covers 2-5 cm below the
gastroesophageal junction, while gastroesophageal
varices type two lines up until gastric fundus. Isolated
gastric varices type 1 is placed on gastric fundus while
the type two widen until gastric antrum.7
PATHOGENESIS
Several theories of mechanism may explain the
pathogenesis of gastric varices. First theory is
thrombosis in splenic vein that causes isolated gastric
varices. The etiology of splenic vein thrombosis was
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associated with some pathological condition such as
neoplasma, pancreatitis, trauma, pseudocyst,
hypercoagulable state, etc. If the obstruction is at the
distal of left gastric vein, the collateral circulation will
across short gastric vein to gastric fundus.6-8 Other
condition that may cause gastric varices is portal
hypertension. The portal hypertension might be cirrhotic
or non cirrhotic.
In portal hypertension the obstruction of portal blood
flow may occur as well as the vascular resistance. In
addition, hyper-dynamic circulation in liver cirrhosis and
collateral system cause increased cardiac output and
increased intra variceal pressure. Renin-Angiotensin-
Aldosteron system, endothelin and nitric oxide implicate
on vasodilatation of splanchnic vascular. Apart from that,
collagenation of liver stelate cell would also affect the
increase of portal pressure.4
Non cirrhotic portal hypertension is a pathological
condition of increased portal pressure caused by
intrahepatic or prehepatic lesions without liver cirrhosis.
Common lesion found in portal hypertension and liver
cirrhosis is vascular disorder in the portal vein or
perisinusoidal region.9
Common causes of non cirrhotic portal hypertension
can be seen as follows:5
1. Extra-hepatic obstruction of portal vein
2. Non cirrhotic portal fibrosis or idiopathic portal
hypertension
3. Schistosomiasis
4. Primary or secondary biliary cirrhosis
5. Congenital hepatic fibrosis
6. Veno-occlusive disease
7. Nodular regenerative hyperplasia
8. Partial nodular transformation
9. Hepatoportal sclerosis
10. Peliosis hepatitis
Gastric varices may arise due to complication of
schlerotherapy treatment of esophageal varices.4
DIAGNOSIS
Clinical Manifestation
The important clinical manifestation of gastric varices
is upper gastrointestinal bleeding and it is also the
advanced complication.1,10 Blood that is vomited is
usually dark colored and does not coagulate due to
contamination of gastric acid. However, if the vomit is
containing fresh blood, it indicates massive bleeding.
Calculation of blood loss is important for appropriate
management. Intestinal lumen has the reserve capacity
of blood before it is vomited or expelled from the anus.
Postural hypotension describes the possibility of blood
loss about 40%. Serial evaluation of hemoglobin and
hematocryt can be used to calculate amount of blood
transfusion needed.1,10
Other symptoms that might be found are
splenomegaly and ascites as sign of portal hypertension.
Physical examination is important to find out the
underlying cause of portal hypertension to be cirrhotic
or non cirrhotic. The presence of spider nevi, palmar
erythema and jaundice suggest chronic liver disease. The
liver function test and abdominal ultrasound are also
needed. The diagnosis of liver cirrhosis is confirmed by
liver biopsy.4
Angiography is performed to evaluate thrombosis and
blood flow in portal or splenic vein. Left gastric vein is
the main vessel forming the esophageal varices. The
posterior and short gastric veins are the main vessels
involved in the formation of gastric varices.5,7
Splenoportography can also be used to evaluate throm-
bus in splenic or portal vein.7
Endoscopy
Endoscopy is the main diagnostic tool to confirm
diagnosis of gastroesophageal varices. It has important
role to determine the source of bleeding as well as
theurapetic modality for variceal bleeding.1,11 Gastric
varices may be more difficult to identify at endoscopy
because they are generally situated deeper than
esophageal varices and may resemble rugal folds.3 In
acutely bleeding patients, the fundus is frequently
obscured by a pool of blood and small gastric varices
may not be easily detected. Endoscopy examination
revealed red spot as localized eritematous area in
gastric mucosa. Histologic features of red spot are not
very clear. The presence of red spot indicates trauma in
gastric mucosa and risk of bleeding in gastric varices.12
Vascular structure of gastric varices is different
compare to esophageal varices. Red-color sign is not
commonly found in gastric varices. Red-color sign
indicates dilatation of vessel aligning mucosal epithelium
of esophageal varices, while gastric varices is usually
placed in the submucosal layer. Based on its size, gastric
varices are classified into several categories:12
1. Small, if the size less than 5 mm
2. Medium, if the size between 5 and 10 mm
3. Large, if the size more than 10 mm
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MANAGEMENT OF GASTRIC VARICES
1. Primary Prevention to Prevent Bleeding of
Varices
The most important pharmacologic therapy to
prevent variceal bleeding is the one that has the
capacity to reduce portal hypertension. The drugs which
are able to decrease portal vein collateral or intrahepatic
vascular resistance can be used such as beta blockers,
nitrates, alpha blocker, spirinolacton and pentoxiphyllin.
Variceal bleeding will not occur if the hepatic vein
pressure gradient is less than 12 mmHg, so the theurapetic
goal is to reduce the pressure as closer as possible to
that number.2
Beta blockers will reduce portal pressure, sphlancnic
and collateral blood flow. The non-selective beta blockers
like propanolol and nadolol are more useful because the
blocking effect on ß1 adrenergic receptor cause
splanchnic vasoconstriction. Decrease of portal vein
pressure by 20% or hepatic vein pressure gradient less
than 12 mmHg was associated with significant
protection from bleeding. If the equipment to measure
hepatic vein pressure gradient is not available, beta
blockers can be titrated until heart rate at rest reach 55
beats per minute or there is 25% reduction from baseline
heart rate.2,13 Nadolol can also be used in primary
prevention. The advantage of nadolol is that it can be
given as single dose.4,14
The effectiveness of beta blockers for primary
prevention had been shown in several controlled
studies. Meta-analysis showed significant decrease in
risk of bleeding and mortality rate.13 Beta blockers should
be given carefully in severe and active bleeding because
they might disturb resuscitation process and precipitate
hepatic encephalopathy.15
Other drug can be used is isosorbid mononitrates.
The mechanism of nitrates remains unclear. It is assumed
that nitrate has the capacity to reduce intrahepatic
pressure, decrease portal pressure due to splanchnic
vasoconstriction as response to peripheral vasodilatation.2
Unfortunately, nitrate can not be used as monotherapy.
However, study by Angelico et al observed the use of
isosorbid mononitrate as monotherapy in comparison to
propanolol in primary prevention. The results showed
that nitrate was as effective and safe as propanolol.16
Several studies had showed that the use combination
of isosorbid mononitrate and propanolol had given better
result than each drug used as monotherapy.2,4,17
2. Controlling Active Bleeding
General Management
The principal management of acute bleeding due to
gastric varices is the same as management of other
upper gastrointestinal bleeding. First measure to be done
is to improve the general condition and stabilize vital signs.
Fluid resuscitation using crystalloid such as normal
saline (NaCl) or ringer lactate and plasma expander such
as colloid if needed. Blood transfusion of packed red
cell is given after fluid resuscitation. It may be
necessary to consider giving coagulation factors such as
fresh frozen plasma especially for patients with liver
cirrhosis. Whole blood can be used in massive
bleeding.1
Gastric lavage using the iced water or NaCl
solution is useful as diagnostic tool and theurapetic
intervention. Appropriate gastric lavage technique is
important to prevent trauma at upper gastrointestinal
mucosa.1,18
Endoscopic exploration is necessary to find the source
of bleeding and confirm the diagnosis. There are two
alternatives, emergency endoscopy or early endoscopy.
Emergency endoscopy may be able to locate the source
of acute bleeding and perform therapeutic intervention
concomitantly. Emergency endoscopy is technically dif-
ficult and need high competency, adequate equipment
and completes resuscitation team.1
Early endoscopy is done when patient’s condition has
been stable. Vasoactive drugs are given either to stop or
to prevent bleeding.
Vasoactive drugs
Vasoactive drugs used for this condition:1,2,6,7,18
1. Vasopressin
This drug attenuates bleeding by splanchnic
vasoconstriction and cause reduction portal pressure
and blood flow. The recommended dose is 0.2-
0.4 unit/minute for 1 to 24 hours. Vasopressin is given
by intravenous continuously due to its short half-life.
The side effect of this drug is systemic
vasoconstriction that can cause myocardial
infarction and mesenteric ischemia. Thus, it should
be very careful when giving it to elderly patient and
it is contraindicated in patients with heart disease.
2. Somatostatin and octreotide
These drugs have been used commonly in upper
gastrointestinal bleeding due to its effect in
decreasing splanchnic and portal pressure without
significant complications. In addition, they can also
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inhibit the secretion of gastric acid and pancreatic
enzyme as well as decrease the blood flow to the
stomach. The recommended doses are:
• Somatostatin: 250 mcg bolus followed by
continuous infusion of 250 ìg/h
• Octreotide: continuous infusion of 50 ìg/h
Endoscopic Treatment
Sclerotherapy and ligation for gastric varices are not
as effective as for esophageal varices in controlling acute
bleeding because gastric varices is localized deeper in
the gut wall. The treatment of choice is injection of glue
cyanoacrylate. It will make contact to blood and form
plaque on site of bleeding. This glue contains lipiodol
mixture delayed polymeration. If the needle has been
inserted into the varices, glue cyanoacrylate will be
injected and lipiodol will be used to assist the glue
reaching the source of bleeding. In addition, a small
non-controlled study had showed that endoscopic
ligation with detachtable minisnare is also effective to
control bleeding due to gastric varices.2 Experience
using rubber band ligation in our hospital had indicated
satisfying result.1
Balloon Tamponade
Balloon used for gastric varices called Linton-
Nicholas is a single, large size gastric balloon (600 cc).
This balloon was commonly used to stop acute bleeding
due to fundal varices. Balloon tamponade was actually
effective in controlling bleeding, but the incidence of
rebleeding was high. The common complications were
rupture, respiratory tract obstruction and aspiration.
Balloon tamponade still can be used for patients who
are failed to endoscopic treatment or rebleed after
endoscopic treatment.8
Transjugular Intrahepatic Portosystemic Shunt (TIPS)
TIPS is a percutaneus treatment making the
connection between portal vein and hepatic vein. The
methods used were to implant metal stent as the bridge
between portal vein and hepatic vein via transjugular
vein.8 The goal of this treatment is decompression of
portal system to systemic vein without conducting
surgical treatment.
Among complications of TIPS are hepatic
encephalopathies, portal stenosis or stent occlusion.
Stenosis were more common than occlusion due to
intimal hyperplasia.13 The advantage of TIPS in
comparison to surgical procedure is the low mortality
rate.8 In addition, 5% to 10% patients with refractory
acute variceal bleeding including gastric varices would
response very well and stop the bleeding.19 Mortality
rate of TIPS were high in elderly patients and those who
have multi organ failure reaching almost 100%.2
3. Secondary Prevention to Prevent Rebleeding
Secondary prevention is done to prevent the
recurrence of variceal bleeding. Two of three patients
would rebleed in 6 weeks after first episode. Clinical
predictor for bleeding recurrence are bleeding severity
in initial bleeding, stage of liver decompensation, the
presence of encephalopathy hepaticum and decreased
renal function.2
Pharmacologic Therapy
Decrease portal pressure of more than 20% will
decrease bleeding recurrence. Some drugs have been
used to decrease portal pressure as secondary
prevention. One of them, non selective beta blocker had
been used commonly and its effectiveness had been
proved by several studies. The combination of beta
blocker and isosorbide mononitrate in patients with liver
cirrhosis child A-B was superior compare to those with
sclerotherapy.14 Other study showed more effective
pharmacologic therapy compare to ligation in patients
with liver cirrhosis child A, B.20
Endoscopic Treatment
Sclerotherapy and ligation are not effective for
gastric varices. The best management of patients with
bleeding recurrence due to gastric varices is N-buthyl-
cyanoacrylate injection.2
Transjugular Intrahepatic Portosystemic Shunt
(TIPS)
TIPS is more effective in prevention of bleeding
recurrence compare to endoscopic treatment.
Significant increased incidence of hepatic encelopathy
in 25% patients after shunting. Besides, TIPS did not
increase life expectancy compare to endoscopic
treatment in patients with advanced liver disease and
gave bad result after shunting. TIPS could be used as
bridging therapy before liver transplantation in patients
with advanced liver disease.2 TIPS gave better result
and was less  expensive  compare to distal splenorenal
shunt.   However, TIPS is recommended mainly for child
A liver cirrhosis due to high incidence of TIPS
complication.21
Surgical Therapy
Surgery is conducted as emergency or elective
procedure. Emergency surgery is indicated in patients
of 1st and 2nd degree of criticalness. The classifications
of criticalness are as follows:20
1st degree of criticalness : need blood transfusion more
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than two liters in the first 8
hours to maintain adequate
circulation.
2nd degree of criticalness : need blood transfusion more
than two liters in the first 24
hours to maintain adequate
circulation
3rd degree of criticalness : bleeding still active after 72
hours since hospital
admission
Elective surgery to prevent rebleeding due to gastric
varices is usually performed after six weeks after bleeding
has stopped. Surgical procedure in portal hypertension
is divided into categories as follows:
1.   Shunt decompression, classified into total, partial and
selective decompression.
a. Total Portal Systemic Shunt
One of technique had been used was portocaval
shunt that can be conducted end to end or side
to side. In portocaval shunt, the portal vein is
connected to inferior cava vein and caused
decreased portal pressure and hepatic vein
pressure to increase the hepatic artery blood
flow.7,15 Recently, portocaval shunt technique is
rarely used due to high incidence of
complications.
Other technique used in total-portal systemic
shunt is mesocaval shunt which makes the
connection between superior mesenteric vein and
inferior cava vein using Dacron graft. This
technique is not difficult and portal vein will stay
open, although direction of blood flow cannot be
determined. Shunt occlusion commonly occurs
and usually followed by bleeding recurrence.6
The most popular mesocaval technique was
H-graft shunt by Drapanas and Cameron. Graft
connected mesenteric superior vein that placed
inferior of pancreas with inferior cava vein that
placed below insertion of renal vein.
b. Partial Porto Systemic Shunt
This technique is based on principal to limit   portal
systemic shunt while conducting decompression
to control bleeding, thus it will keep maintaining
relatively sufficient blood flow to portal system
in the liver.7 Central splenorenal shunt is one of
technique with the same goal, but according to
Sharfen et al, the definition of partial shunt is
shunt interposition between portal vein and
inferior cava vein with diameter of 8 mm. The
difficulty of this technique is maintaining size of
shunt without causing thrombosis or stenosis. The
advantage of the technique is the lower incidence
of hepatic encelopathy compare to total shunt.
c. Selective Varices Decompression
There are two types of selective shunt. The most
commonly used is the distal splenorenal shunt
which could selectively decompress spleen and
gastroesophageal to the left lienalis vein,
superior mesenteric vein and portal vein to
maintain portal blood flow. The other type is
coronary caval shunt which was popularized by
Inokuchi. It makes anastomosis of left gastric
vein and inferior cava vein and usually
splenectomy is also conducted.7
2. Devascularisation procedure
This technique is suggested if the shunt operation is
difficult to be done. Sugiura and Futugawa had
popularized the esophagogastric devascularization
with splenectomy and trisection of esophagus. It is
an alternative therapy for patient with liver cirrhosis
who is not eligible for shunt procedure or those with
extrahepatic portal vein thrombosis.21
CONCLUSION
Upper gastrointestinal bleeding is an emergency
condition in the field of gastroenterology with high
morbidity and mortality rate. One of the causes of upper
gastrointestinal bleeding is the rupture of gastric varices
which can be fatal and difficult to control although it is
relatively small in frequency. The pathogenesis of
gastric varices is thrombosis of splenic vein and cirrhotic
or non-cirrhotic portal   hypertension. Endoscopy is the
main modality in making diagnosis of gastric varices.
The management of gastric varices is divided into
three phases: primary prevention, control active bleed-
ing and secondary prevention by pharmacologic therapy,
endoscopy, TIPS or surgical treatment.
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